Abused drug assay kit EMIT® II Plus

for heroinurinelaboratory

The EMIT® II Plus 6-Acetylmorphine Assay accurately detects heroin use, without cross-reactivity to morphine, morphine metabolites, and many common analgesics. Siemens offers a convenient and effective way to selectively test for heroin use and enables your laboratory to adjust to changing testing requirements. High specificity for 6-Acetylmorphine (6-AM) No cross-reactivity to morphine, morphine metabolites, and common analgesics Qualitative (10 ng/mL cut-off) and semi-quantitative results Low analytical sensitivity of 1.1 ng/mL* >99% agreement with the reference method (GC/MS) Features & Benefits Maintain a high level of integrity in your drug testing program, with the addition of the Emit® II Plus 6-Acetylmorphine Assay to your current offering. Over the past decade, the number of heroin confiscations has more than doubled.1 Furthermore, an increasing amount of morphine-type drugs are prescribed as analgesics that can cross-react with traditional opiate assays. Can a rapid screen differentiate heroin use from prescribed or ‘over-the-counter’ medications? The presence of the heroin metabolite 6-Acetylmorphine (6-AM) in urine specifically confirms the use of heroin. The new EMIT II Plus 6-Acetylmorphine Assay is intended for the qualitative and semi-quantitative determination of 6-AM in human urine, at a cut-off value of 10 ng/mL. This new assay meets the Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines for Federal Workplace Testing. The EMIT® II Plus 6-Acetylmorphine Assay provides: High specificity for 6-Acetylmorphine (6-AM) No cross-reactivity to morphine, morphine metabolites, and common analgesics